Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line

International Immunopharmacology

Volumn 6, Issue 6, 2006, Pages 1013-1019

  Parkhill, Amy L ^a   Bidlack, Jean M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

ELISA; Interleukin 6; Kappa opioid receptor; Monocyte; RT PCR

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; INTERLEUKIN 6; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; LIGAND; LIPOPOLYSACCHARIDE; MESSENGER RNA; NORBINALTORPHIMINE; OPIATE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE SYSTEM; IMMUNITY; IMMUNOSTIMULATION; INHIBITION KINETICS; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; GENE EXPRESSION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MONOCYTES; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; RECEPTORS, OPIOID, KAPPA; RNA STABILITY; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646112629     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.01.012     Document Type: Article

References (30)

1. Bidlack J.M. Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol 7 (2000) 719-723
2. Sharp B.M., Roy S., and Bidlack J.M. Evidence for opioid receptors on cells involved in host defense and the immune system. J Neuroimmunol 83 (1998) 45-56
3. Rogers T.J., and Peterson P.K. Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol 24 (2003) 116-121
4. Bidlack J.M., Saripalli L.D., and Lawerence D.M. Kappa-opioid binding sites on a murine lymphoma cell line. Eur J Pharmacol 227 (1992) 257-265
5. Carr D.J.J., DeCosta B.R., Kim C.-H., Jacobson A.E., Guarcello V., Rice K.C., et al. Opioid receptors on cells of the immune system: evidence for δ- and κ-classes. J Endocrinol 122 (1989) 161-168
6. 1. Life Sci 49 (1991) 45-51
7. Alicea C., Belkowski S.M., Sliker J.K., Zhu J., Liu-Chen L.Y., Eisenstein T.K., et al. Characterization of κ-opioid receptor transcripts expressed by T cells and macrophages. J Neuroimmunol 91 (1998) 55-62
8. Chao C.C., Gekker G., Sheng W.S., Hu S., and Peterson P.K. U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages. Drug Alcohol 62 (2001) 149-154
9. Gunji N., Nagashima M., Asano G., and Yoshino S. Expression of kappa-opioid receptor mRNA in human peripheral blood lymphocytes and the relationship between its expression and the inflammatory changes in rheumatoid arthritis. Rheumatol Int 19 (2000) 95-100
10. Alicea C., Belkowski S., Eisenstein T.K., Adler M.W., and Roger T.J. Inhibition of primary murine macrophage cytokine production in vitro following treatment with κ-opioid agonist U50,488H. J Neuroimmunol 64 (1996) 83-90
11. Belkowski S.M., Alicea S., Eisenstein T.K., Adler M.W., and Rogers T.J. Inhibition of interleukin-1 and tumor necrosis factor-α synthesis following treatment of macrophages with the kappa opioid agonist U50,488H. J Pharmacol Exp Ther 273 (1995) 1491-1496
12. Wilson J.L., Nayanar V., and Walker J.S. The site of anti-arthritic action of the kappa agonist, U50488H: importance of local administration. Br J Pharmacol 118 (1996) 1754-1760
13. Walker J.S. Anti-inflammatory effects of opioids. Adv Exp Med Biol 521 (2003) 148-160
14. Levy J.H. The human inflammatory response. J Cardiovasc Pharmacol 27 (1996) S31-S37
15. Nishimoto N., and Kishimoto T. Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmcol 4 (2004) 386-391
16. Azuma Y., and Ohura K. Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NF-kB DNA binding in THP-1 differentiated to macrophage-like cells. Scand J Immunol 56 (2002) 260-269
17. Gomez-Flores R., Rice K.C., Zhang X., and Weber R.J. Increased tumor necrosis factor-alpha and nitric oxide production by rat macrophages following in vitro stimulation and intravenous administration of the delta-opioid agonist SNC 80. Life Sci 68 (2001) 2675-2684
18. Kowalski J., Makowiecka K., Belowski D., and Herman Z.S. Augmenting effect of methionine-enkephalin on interleukin-6 production by cytokine-stimulated murine macrophages. Neuropeptides 34 (2000) 187-192
19. Sacerdote P. Effects of in vitro and in vivo opioids on the production of IL-12 and IL-10 by murine macrophages. Ann N Y Acad Sci 992 (2003) 129-140
20. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
21. Sweet M.J., and Hume D.A. Endotoxin signal transduction in macrophages. J Leukoc Biol 60 (1996) 8-26
22. Roy S., Cain K.J., Chapin R.B., Charboneau R.G., and Barke R.A. Morphine modulates NFκB activation in macrophages. Biochem Biophys Res Commun 245 (1998) 392-396
23. Welters I.D., Menzebach A., Goumon Y., Cadet P., Menges T., Hughes T.K., et al. Morphine inhibits NF-κB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology 92 (2000) 1677-1684
24. Sheng W.S., Hu S., Lokengard J.R., and Peterson P.K. U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol 65 (2003) 9-14
25. Bretz J.D., Williams S.C., Baer M., Johnson P.F., and Schwartz R.C. C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. Proc Natl Acad Sci U S A 91 (1994) 7306-7310
26. Hu H.M., Tian Q., Baer M., Spooner C.J., Williams S.C., Johnson P.K., et al. The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J Biol Chem 275 (2000) 16373-16381
27. Melnicoff M.J., Horan P.K., and Morahan P.S. Kinetics of changes in peritoneal-cell populations following acute inflammation. Cell Immunol 118 (1989) 178-191
28. Ishihara K., and Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13 (2002) 357-368
29. Goldblatt F., and Isenberg D.A. New therapies for rheumatoid arthritis. Clin Exp Immunol 140 (2005) 195-204
30. Suffredini A.F., Fantuzzi G., Badolato R., Oppenheim J.J., and O'Grady N.P. New insights into the biology of the acute phase response. J Clin Immunol 19 (1999) 203-214